Page last updated: 2024-08-25

enocitabine and Myelodysplastic Syndromes

enocitabine has been researched along with Myelodysplastic Syndromes in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawauchi, K; Ogasawara, T; Yasuyama, M1
Hotta, T; Ichikawa, A; Ito, T; Kagami, Y; Ohashi, H; Saito, H1
Iwakiri, R; Kumakawa, T; Mikoshiba, M; Mori, M; Ohta, M; Tsutsumi, H1
Abe, T; Fujii, H; Horiike, S; Inazawa, J; Misawa, S; Nakagawa, H; Sonoda, Y; Tanaka, S; Taniwaki, M; Tsuda, S1
Dohy, H; Kyo, T1
Ota, K1

Reviews

1 review(s) available for enocitabine and Myelodysplastic Syndromes

ArticleYear
Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
    American journal of hematology, 2005, Volume: 79, Issue:2

    Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 5; Cytarabine; Cytogenetic Analysis; Etoposide; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Monosomy; Myelodysplastic Syndromes

2005

Other Studies

5 other study(ies) available for enocitabine and Myelodysplastic Syndromes

ArticleYear
Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy.
    Leukemia, 1994, Volume: 8, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Female; Hematopoiesis; Humans; Methotrexate; Methylation; Middle Aged; Myelodysplastic Syndromes; Polymorphism, Restriction Fragment Length; Remission Induction

1994
Prognosis of elderly patients with acute myelogenous leukemia: analysis of 126 AML cases.
    International journal of hematology, 2002, Volume: 75, Issue:1

    Topics: Acute Disease; Age Factors; Aged; Allopurinol; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cholinesterases; Cytarabine; Daunorubicin; Disease Progression; Female; Humans; Japan; Karyotyping; Leukemia, Myeloid; Life Tables; Male; Mercaptopurine; Middle Aged; Myelodysplastic Syndromes; Neoplasm Proteins; Prognosis; Remission Induction; Risk Factors; Survival Analysis; Survival Rate

2002
[Relation of karyotypic findings to chemotherapy response in patients with preleukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 2-3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chromosome Aberrations; Chromosomes, Human, Pair 5; Chromosomes, Human, Pair 7; Cytarabine; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Preleukemia

1989
Results of aggressive chemotherapy for myelodysplastic syndromes.
    Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society, 1988, Volume: 51, Issue:8

    Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Male; Mercaptopurine; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Remission Induction; Vincristine

1988
[Cytarabine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:10

    Topics: Animals; Antineoplastic Agents; Cytarabine; Humans; Leukemia, Myeloid, Acute; Mice; Myelodysplastic Syndromes; Structure-Activity Relationship

1987